Publications
Jindal T, Jiang CY, Alhalabi O, Nguyen CB, Oh E, Tsung I, Bakaloudi DR, Talukder R, Davidsohn M, Freeman D, Epstein IY, Ding CC, Nizam A, Glover MJ, Khaki AR, Taylor AK, Lemke E, Jang A, Evans ST, Shin D, Pywell C, Basu A, Bilen MA, Zakharia Y, Barata P, Milowsky MI, Brown J, Kilari D, Emamekhoo H, Hoimes CJ, Shah S, Davis NB, Gupta S, Grivas P, Bellmunt J, Alva A, Campbell MT, Koshkin VS. Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study. European urology. 2025. PMID: 40954009
Courau T, Desai A, Wagner A, Combes AJ, Krummel MF. The coming era of nudge drugs for cancer. Cancer cell. 2025. PMID: 40939589
Chang K, Delavan HM, Yip E, Kasap C, Zhu J, Lodha R, Liao SY, Berman SC, Carretero-Gonzalez A, Basar M, Gokturk Ozcan G, Teo MY, Solit DB, Rosenberg JE, Al-Ahmadie H, Ding CCK, Chan E, Steri V, Porten SP, Koshkin VS, Friedlander TW, Feng FY, Lee JK, Wiita AP, Chu CE, Chou J. Modulating the PPAR? pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. Nature communications. 2025. PMID: 40931013
Wang M, Komanduri KV, Datta D, Patel A, Whitaker B, Belov A, Rubin B, Vashist R, Rodriguez-Monguio R, Cinar P, Anderson SA, Butte AJ. An AI Model Classifies Risks of Early Relapse Post-CAR T Cell Therapy in a Multi-Center Real-World Population with DLBCL. Blood advances. 2025. PMID: 40902085
Jang A, Tripathi N, Lanka SM, Kumar HLS, Jain P, Calaway A, Shoag JE, Vince R, Mendiratta P, Rao S, Garcia JA, Brown JR, Koshkin VS, Campbell MT, Singh P, Barata PC. Advanced urothelial carcinoma treated with enfortumab vedotin and pembrolizumab: a path to cure? The oncologist. 2025. PMID: 40828887
Hall K, Lazaryan A, Der Laan MV, Lee CJ, Logan AC, Gruber S, Kabadi S, Khan I, Nicholls C, Rota LM, Nikai E, Ponomareva E, Koumas A, Waller EK. Efficacy and Safety of Belumosudil as Compared with Best Available Therapy for the Treatment of cGVHD in the US. Blood advances. 2025. PMID: 40875591
O'Connor TE, Lin C, Roloff GW, Zhang A, Miller K, Aldoss I, Kopmar NE, Dekker SE, Gupta VK, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed N, Sutherland K, Dykes KC, Ahmed M, Chen E, Zambrano H, Bradshaw D, Mercadal S, Schwartz M, Tracy S, Connor MP, Kubiak M, Mukherjee A, Majhail N, Battiwalla M, Mountjoy L, Malik SA, Mathews J, Shaughnessy P, Blunk B, Logan AC, Ladha A, Advani AS, Stefan M, Guzowski C, Hoeg RT, Hilal T, Moore J, O'Dwyer KM, Hill LC, Sasine J, Oliai C, Solh MM, Lee CJ, Kota VK, Koura D, Kumaran MV, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Pullarkat V, Bishop MR, Stock W, Cassaday RD, Shah BD, Faramand R, Muffly LS, Tsai SB, Dholaria B. The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Bone marrow transplantation. 2025. PMID: 40849364
Taiwo R, Harary PM, Trinh TTH, Granucci M, Bertrand S, Carlson-Clarke B, Chernikova SB, Therkelsen K, Arora M, Melisko ME, Iv M, Vogel H, Han S, Xie C, Brain S, Lee V, Bharani KL, Nagpal S, Hayden Gephart M. Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases. BMC cancer. 2025. PMID: 40813655
Nira Krasnow, Michelle Jayaraj, Mia Salans, Kelsey Kuwahara, Maggie Zhou, Samantha Fisch, Lauren Boreta, Steve Braunstein, Ramin Morshed, Harish Vasudevan, Jo Chien, Melanie Majure, Hope Rugo, Michelle Melisko, Laura Huppert. TRLS-13 CLINICAL CHARACTERISTICS AND OVERALL SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER AND BRAIN METASTASES: A SINGLE CENTER RETROSPECTIVE COHORT STUDY. Neuro-oncology advances. 2025. PMID:
Rahmani R, Kang H, Chan JW. A Patient With Prior Skin Cancers and New Diagnosis of Bell Palsy. JAMA oncology. 2025. PMID: 40773185
Tolani MA, Agbo CA, Umar SS, Paciorek A, Ojewola RW, Mohammed F, Maiga M, Kaninjing E, Ahmed M, DeBoer R. An intervention mapping approach to the development and evaluation of a community-based prostate cancer early detection programme in Nigeria. PLOS global public health. 2025. PMID: 40763189
Caston NE, Deng L, Williams CP, Levitan EB, Azuero A, Griffin R, Smith KL, Wolff AC, Melisko ME, Shinn EH, Gallagher K, Angove R, Wheeler SB, Rocque GB. Understanding Associations Between Patient-Level Factors and Participation in a Breast Cancer Clinical Trial. Cancer medicine. 2025. PMID: 40836443
Hawes MR, Chakravarty D, Cheng J, Handley MA, Tsoh JY, Lin TK, Hiatt RA, Vijayaraghavan M. The Healthy Homes Study: Protocol for a cluster randomized trial of a place-based smoke-free home intervention in affordable housing. PloS one. 2025. PMID: 40729126
Hawes M, Alway J, Chakravarty D, Kushel M, Max W, Xia F, Neyazi N, Vijayaraghavan M. Cigarette smoke-free home adoption attempts among formerly homeless adults living in permanent supportive housing. Drug and alcohol dependence reports. 2025. PMID: 40762021
Brooks TR, Zabor EC, Bedelu Y, Yang X, Karimi YH, Nedved AN, Wang Y, Dave NK, Landsburg DJ, Baron K, Hu B, Trotier D, Pophali PA, Miller J, Grover NS, Reinert C, Major A, Schwarz T, Patel K, Salafian K, Ayers EC, Sundaram S, Brody JD, McKenna M, Tiger YKR, Sears-Smith M, Ghosh N, Peterson C, Khan C, Bliven SP, Narkhede M, Gibson A, Kline J, Munoz J, Garza Morales R, Ho C, Smith SD, Niu A, Hernandez-Ilizaliturri FJ, Chinyengetere F, Dave SS, Abdel-Razeq N, Alhaj Moustafa M, Caimi P, Hill BT. Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab. Blood. 2025. PMID: 40663785
Wong MK, Milhem MM, Sacco JJ, Michels J, In GK, Couselo EM, Schadendorf D, Beasley GM, Niu J, Chmielowski B, Wise-Draper TM, Bowles TL, Tsai KK, Lebbé C, Gaudy-Marqueste C, Middleton MR, Skolariki A, Samson A, Chesney JA, VanderWalde AM, Zakharia Y, Harrington KJ, Appleton E, Bommareddy PK, Zhu J, Viana M, Hou JW, Coffin RS, Robert C. RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025. PMID: 40627813
Kwarteng LA, Lee AY, Sakafu L, Mango VL, Fundikira LS, Lyimo F, Kwikima U, Mushi BP, Van Loon K, Minja FJ. Global radiology: Building equitable and effective partnerships with low and middle-income countries. Clinical imaging. 2025. PMID: 40633489
Kennedy VE, Ahmed N, Artz A, Bhatt NS, Custatis R, Espinoza-Gutarra MR, Farhan S, Ferguson RJ, Hamilton B, Katz H, Kelly DL, Knight JM, Lee C, Lin A, Lin R, Mohanraj L, Munshi P, Nawas M, Nelson AM, Odstracil S, Olin R, Phelan R, Rentscher KE, Schoemans H, Sung A, Taylor MR, Wood W, Yuen CH, Jayani-Kosarzycki RV. Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Transplantation and cellular therapy. 2025. PMID: 40614969
Le P, Ung L, Yang H, Huang A, He T, Bruno P, Oh DY, Keenan BP, Zhang L. PepTCR-Net: prediction of multi-class antigen peptides by T-cell receptor sequences with deep learning. Briefings in bioinformatics. 2025. PMID: 40702702
Miller CR, Huang Y, Allan JN, Bhat SA, Bond D, Brander D, Byrd JC, Chavez J, Chong E, Danilov A, Dowling MR, Dvorak-Kornaus K, Hampel PJ, Ho C, Islam P, Malakhov N, Matasar M, Miller S, Parikh SA, Rabe KG, Rhodes JM, Roeker LE, Rogers KA, Saha A, Skarbnik A, Scott H, Schade J, Shadman M, Shouse G, Stephens DM, Thompson MC, Thompson PA, Wang Y, Woyach JA, Yano M, Omer Z, Kittai AS. Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era. American journal of hematology. 2025. PMID: 40600589